These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 25966424)

  • 41. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A; Wittekind C
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type Lesions.
    Masetto F; Mafficini A; Saka B; Armutlu A; Chatterjee D; Jang KT; Zen Y; Navale P; Fassan M; Bacchi CE; Mattiolo P; Simbolo M; Ruzzenente A; Lawlor RT; Reid M; Basturk O; Adsay V; Scarpa A; Luchini C
    Am J Surg Pathol; 2024 Sep; 48(9):1082-1092. PubMed ID: 38946053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.
    Chong DQ; Zhu AX
    Oncotarget; 2016 Jul; 7(29):46750-46767. PubMed ID: 27102149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholangiocarcinoma: molecular pathways and therapeutic opportunities.
    Ilyas SI; Borad MJ; Patel T; Gores GJ
    Semin Liver Dis; 2014 Nov; 34(4):456-64. PubMed ID: 25369307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
    Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
    Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells.
    Duwe L; Munoz-Garrido P; Lewinska M; Lafuente-Barquero J; Satriano L; Høgdall D; Taranta A; Nielsen BS; Ghazal A; Matter MS; Banales JM; Aldana BI; Gao YT; Marquardt JU; Roberts LR; Oliveira RC; Koshiol J; O'Rourke CJ; Andersen JB
    J Hepatol; 2023 Feb; 78(2):364-375. PubMed ID: 36848245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.
    Raggi C; Invernizzi P; Andersen JB
    J Hepatol; 2015 Jan; 62(1):198-207. PubMed ID: 25220250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenesis of Cholangiocarcinoma.
    Rodrigues PM; Olaizola P; Paiva NA; Olaizola I; Agirre-Lizaso A; Landa A; Bujanda L; Perugorria MJ; Banales JM
    Annu Rev Pathol; 2021 Jan; 16():433-463. PubMed ID: 33264573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic and epigenetic abnormalities in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Timmer MR; Beuers U; Fockens P; Ponsioen CY; Rauws EA; Wang KK; Krishnadath KK
    Inflamm Bowel Dis; 2013 Jul; 19(8):1789-97. PubMed ID: 23615529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular profiling reveals potential targets in cholangiocarcinoma.
    Liu D; Shi Y; Chen H; Nisar MA; Jabara N; Langwinski N; Mattson S; Nagaoka K; Bai X; Lu S; Huang CK
    World J Gastroenterol; 2023 Jul; 29(25):4053-4071. PubMed ID: 37476584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma?
    Bickenbach K; Galka E; Roggin KK
    Surg Oncol Clin N Am; 2009 Apr; 18(2):215-24, vii. PubMed ID: 19306808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histological type of intrahepatic cholangiocarcinoma differentiated by genetic alteration from AP-PCR fingerprint.
    Chuensumran U; Saelee P; Wongkham S; Pairojkul C; Chauin S; Petmitr S
    Asian Pac J Cancer Prev; 2011; 12(6):1377-80. PubMed ID: 22126467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
    Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutational landscape of intrahepatic cholangiocarcinoma.
    Zou S; Li J; Zhou H; Frech C; Jiang X; Chu JS; Zhao X; Li Y; Li Q; Wang H; Hu J; Kong G; Wu M; Ding C; Chen N; Hu H
    Nat Commun; 2014 Dec; 5():5696. PubMed ID: 25526346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy.
    Zaki MB; Abulsoud AI; Elshaer SS; Fathi D; Abdelmaksoud NM; El-Mahdy HA; Ismail A; Elsakka EGE; Sallam AM; Doghish AS
    Pathol Res Pract; 2023 May; 245():154437. PubMed ID: 37030167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholangiocarcinoma.
    Krasinskas AM
    Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells.
    Obama K; Satoh S; Hamamoto R; Sakai Y; Nakamura Y; Furukawa Y
    Clin Cancer Res; 2008 Mar; 14(5):1333-9. PubMed ID: 18316552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-specific marker genes for intrahepatic cholangiocarcinoma: utility and mechanistic insight.
    Blechacz B; Gores GJ
    J Hepatol; 2008 Aug; 49(2):160-2. PubMed ID: 18538440
    [No Abstract]   [Full Text] [Related]  

  • 60. Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma.
    Limpaiboon T; Khaenam P; Chinnasri P; Soonklang M; Jearanaikoon P; Sripa B; Pairojkul C; Bhudhisawasdi V
    Cancer Lett; 2005 Jan; 217(2):213-9. PubMed ID: 15617839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.